Second CRL given to Acacia after ‘continuing deficiencies’

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/NZPhotonz)
(Image: Getty/NZPhotonz)

Related tags: Crl, Acacia, Fda, NDA, API, Gmp, Manufacturing

Acacia Pharma receives a second CRL from the US FDA regarding its NDA, after GMP deficiencies during API production were revealed again.

The US Food and Drug Administration (FDA) sent the company a complete response letter (CRL) after ‘continuing deficiencies’ were found at the unnamed contract manufacturer of the active pharmaceutical ingredient (API) of its drug candidate, Barhemsys (amisulpride injection).

Julian Gilbert, CEO of Acacia, said in a statement, that the company is ‘extremely disappointed’ that the amisulpride manufacturer in its application has still not been able to meet the FDA’s required standards.

Barhemsys is a treatment for post-operative nausea and vomiting. Acacia is focused on the development of anti-nausea and vomiting treatments for surgical and cancer patients. It has a further two product candidates that are based on the same API as Barhemsys in its pipeline.

According to Acacia, the FDA found no concerns with the clinical and non-clinical data submitted in the new drug application (NDA) and no further studies nor data analyses will be required for approval.

“As there were no other issues raised with our application, we remain confident that Barhemsys is approvable. We are on track to complete the qualification of an alternative supplier of amisulpride and plan to engage with the FDA as soon as possible to determine the most rapid route to obtaining approval for Barhemsys,”​ Gilbert added.

After its first CRL​, Acacia remained committed to its API manufacturer stating that that contractor had been working collaboratively with the company to resolve the issue.

Related news

Related products

show more

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more